|

Allogeneic CD7-Targeted CAR-T Cell Injection Clinical Trials

1 actively recruiting trial

Pipeline

Early 1: 1

Top Sponsors

  • Shanghai Zhongshan Hospital1

Indications

  • T1DM - Type 1 Diabetes Mellitus1
  • Diabetes1

Other1 trial

Allogeneic Anti-CD7 CAR-T for Type 1 Diabetes
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.